(Q46610505)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18458820%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

title

Epithelial Growth Factor Receptor Inhibitors for treatment of recurrent or progressive high grade glioma: an exploratory study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18458820%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18458820%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Georg Widhalm

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18458820%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

author name string

E Gelpi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18458820%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

A Rottenfusser

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18458820%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

K Dieckmann

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18458820%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

W Dietrich

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18458820%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

A Bertalanffy

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18458820%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

D Prayer

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18458820%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

J A Hainfellner

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18458820%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Christine Marosi

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18458820%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

publication date

6 May 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18458820%20AND%20SRC:MED&resulttype=core&format=json

Journal of Neuro-Oncology

6 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18458820%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

volume

89

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18458820%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18458820%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

page(s)

211-218

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18458820%20AND%20SRC:MED&resulttype=core&format=json

Immunohistochemical evidence of loss of PTEN expression in primary ductal adenocarcinomas of the breast

6 January 2020

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11060-008-9608-3

Phase I trial of erlotinib with radiation therapy in patients with glioblastoma multiforme: results of North Central Cancer Treatment Group protocol N0177.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11060-008-9608-3

EGFR tyrosine kinase domain mutations in human gliomas

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11060-008-9608-3

Dermatologic side effects associated with the epidermal growth factor receptor inhibitors

21 January 2018

1 reference

12 December 2020

Genetic pathways to primary and secondary glioblastoma

1 reference

12 December 2020

Prognostic value of epidermal growth factor receptor in patients with glioblastoma multiforme

1 reference

12 December 2020

Glioblastoma multiforme and the epidermal growth factor receptor

1 reference

12 December 2020

Randomized phase II trial of erlotinib versus temozolomide or carmustine in recurrent glioblastoma: EORTC brain tumor group study 26034.

1 reference

12 December 2020

Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors.

1 reference

12 December 2020

EGFR targeting of solid tumors

1 reference

12 December 2020

Resistance to tyrosine kinase inhibition by mutant epidermal growth factor receptor variant III contributes to the neoplastic phenotype of glioblastoma multiforme

1 reference

12 December 2020

Response criteria for phase II studies of supratentorial malignant glioma

1 reference

12 December 2020

EGF mutant receptor vIII as a molecular target in cancer therapy

1 reference

12 December 2020

Phase II trial of gefitinib in recurrent glioblastoma

1 reference

12 December 2020

Immunohistochemical detection of EGFRvIII in high malignancy grade astrocytomas and evaluation of prognostic significance

1 reference

12 December 2020

Phase 1 study of erlotinib HCl alone and combined with temozolomide in patients with stable or recurrent malignant glioma

1 reference

12 December 2020

Gefitinib in patients with progressive high-grade gliomas: a multicentre phase II study by Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO).

1 reference

12 December 2020

Analysis of the phosphatidylinositol 3'-kinase signaling pathway in glioblastoma patients in vivo

1 reference

12 December 2020

Changing paradigms--an update on the multidisciplinary management of malignant glioma

1 reference

12 December 2020

Correlation between development of rash and efficacy in patients treated with the epidermal growth factor receptor tyrosine kinase inhibitor erlotinib in two large phase III studies

1 reference

12 December 2020

Erlotinib in cancer treatment.

1 reference

12 December 2020

Epidermal growth factor receptor (EGFR) signaling in cancer

1 reference

12 December 2020

Resistance to small molecule inhibitors of epidermal growth factor receptor in malignant gliomas

1 reference

12 December 2020

Erlotinib in gliomas: should selection be based on EGFR and Akt analyses?

1 reference

12 December 2020

HER1/EGFR tyrosine kinase inhibitors for the treatment of glioblastoma multiforme

1 reference

12 December 2020

Epidermal growth factor receptor inhibition for the treatment of glioblastoma multiforme and other malignant brain tumours

1 reference

12 December 2020

Molecular study of malignant gliomas treated with epidermal growth factor receptor inhibitors: tissue analysis from North American Brain Tumor Consortium Trials 01-03 and 00-01.

1 reference

12 December 2020

Epidermal growth factor receptor, protein kinase B/Akt, and glioma response to erlotinib

1 reference

12 December 2020

10.1007/S11060-008-9608-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18458820%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

1 reference